IL1B and Parkinson disease: A study by Mao et al. showed that NLRP3 inflammasome was involved in PD pathogenesis and inhibition of NLRP3/caspase-1/IL-1β pathways relieved symptoms, providing an approach to PD prevention and therapy [24].